In vitro studies of the combination of imatinib mesylate (Gleevec) and arsenic trioxide (Trisenox) in chronic myelogenous leukemia-Reference-Cited by-同舟云学术

In vitro studies of the combination of imatinib mesylate (Gleevec) and arsenic trioxide (Trisenox) in chronic myelogenous leukemia

Published:2002-07 Issue:7 Volume:30 Page:729-737
ISSN:0301-472X
Container-title:Experimental Hematology
language:en
Short-container-title:Experimental Hematology

Author:

La Rosée Paul,Johnson Kara,O'Dwyer Michael E,Druker Brian J

Publisher

Elsevier BV

Subject

Cancer Research,Cell Biology,Genetics,Hematology,Molecular Biology

Reference49 articles.

1. The biology of chronic myeloid leukemia;Faderl;N Engl J Med,1999

2. The molecular biology of chronic myeloid leukemia;Deininger;Blood,2000

3. An evidence-based analysis of the effect of busulfan, hydroxyurea, interferon, and allogeneic bone marrow transplantation in treating the chronic phase of chronic myeloid leukemia;Silver;Blood,1999

4. Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia;Druker;N Engl J Med,2001

5. Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the Philadelphia chromosome;Druker;N Engl J Med,2001

Cited by 85 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cellular and molecular alterations induced by low‑dose fisetin in human chronic myeloid leukemia cells;International Journal of Oncology;2019-10-02

2. Subcellular co-delivery of two different site-oriented payloads for tumor therapy;Nanoscale;2017

3. Occurrence of BCR/ABL fusion gene in a patient with acute promyelocytic leukemia;Medical Oncology;2014-11-27

4. Identification of Drug Combinations Containing Imatinib for Treatment of BCR-ABL+ Leukemias;PLoS ONE;2014-07-16

5. GFI1 Is Repressed by p53 and Inhibits DNA Damage-Induced Apoptosis;PLoS ONE;2013-09-04